[{"indications": "Indications\u00a0HIV infection in combination with other antiretroviral drugs; low\r\ndoses used to increase effect of some protease inhibitors", "name": "RITONAVIR", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.3 Antiviral drugs", "5.3.1 HIV infection", "Protease inhibitors", "RITONAVIR"], "cautions": "Cautions\u00a0\n(From Protease inhibitors: British National Formulary)\nCautions\u00a0Protease inhibitors are associated with hyperglycaemia and should be used with caution in diabetes (see Lipodystrophy Syndrome). Caution is also needed in patients with haemophilia who may be at increased risk of bleeding.; concomitant use with drugs that prolong PR interval; cardiac conduction disorders, structural heart disease; pancreatitis (see below); interactions: Appendix 1 (ritonavir)Pancreatitis\u00a0Signs and symptoms suggestive of\r\npancreatitis (including raised serum lipase) should be evaluated\u2014discontinue if pancreatitis diagnosed", "side-effects": "Side-effects\u00a0see notes and Cautions above; also diarrhoea (may\r\nimpair absorption\u2014close monitoring required), vasodilatation, cough,\r\nthroat irritation, anxiety, perioral and peripheral paraesthesia,\r\nhyperaesthesia, fever, decreased blood thyroxine concentration, electrolyte\r\ndisturbances, raised uric acid, dry mouth, mouth ulcers, and sweating; less commonly increased prothrombin time and dehydration;\r\nsyncope, postural hypotension, seizures, menorrhagia, and renal failure\r\nalso reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/57196.htm", "doses": ["Initially 300\u00a0mg every 12 hours for 3 days, increased\r\nin steps of 100\u00a0mg every 12 hours over not longer than 14 days to\r\n600\u00a0mg every 12 hours; child over 2\r\nyears initially 250\u00a0mg/m2 every 12 hours, increased by\r\n50\u00a0mg/m2 at intervals of 2\u20133 days to 350\u00a0mg/m2 every 12 hours (max. 600\u00a0mg every 12 hours)"], "pregnancy": "Pregnancy\u00a0manufacturer advises use only if potential benefit\r\noutweighs risk\u2014no information available"}]